Introduction
============

With the advent of assisted reproductive technology (ART), intracytoplasmic sperm injection (ICSI) emerged as a breakthrough in the treatment of severe male infertility. Moreover, satisfactory fertilization and pregnancy rates have been achieved by testicular sperm extraction-intracytoplasmic sperm injection (TESE-ICSI) \[[@B1][@B2]\]. The outcome of TESE-ICSI can be influenced by various factors, including the etiology of azoospermia and the source of the retrieved sperm, in addition to female-related factors such as age and ovarian reserve \[[@B3]\]. The effect of age on fertility is of indisputable clinical relevance \[[@B4]\], and the partner\'s age is also regarded as an important criterion for predicting ICSI outcomes \[[@B5]\]. Similarly, maternal age is one of the most important factors influencing the likelihood of achieving a normal pregnancy by ART.

The effects of maternal age on pregnancy outcomes are well known, particularly the association of advanced maternal age with poor ART results \[[@B4][@B6][@B7][@B8][@B9][@B10]\]. Decreased ovarian reserve and decreased endometrial receptivity resulting from increased age are likely reasons for this observed reduction in fertility \[[@B3][@B11]\], in addition to increased follicle disappearance beginning at the age of 37 years \[[@B11][@B12][@B13][@B14][@B15][@B16]\]. In previous studies, significantly worse pregnancy results were achieved in subjects aged 40 to 49 years than in subjects aged \<40 years \[[@B17][@B18]\]. Consistent with these results, Devroey et al. \[[@B13]\] reported delivery rates of 8.5% and 25.4% per embryo transfer (ET) in women older than and younger than 40 years old, respectively. Additionally, the chance of achieving a successful pregnancy has been shown to be low in women aged ≥41 years \[[@B11]\]. However, maternal age has never been established as a main factor influencing pregnancy results in the most severe cases of male infertility. Similarly, the effects of oocyte and embryo quality (as determined by maternal age) on fertilization outcomes using testicular sperm have not been well established.

Therefore, the present study was performed to examine the possible relationship of clinical outcomes after ICSI with maternal age. This study also aimed to determine if oocyte and embryo quality, which are determined by maternal age, were associated with TESE-ICSI pregnancy results using sperm from partners with azoospermia.

Methods
=======

1. Patients
-----------

From January 2008 through December 2013, to analyze the effects of age on pregnancy outcomes, 416 cycles of ICSI with the partner\'s own testicular spermatozoa were analyzed. Female patients were stratified into the following age categories: 27 to 31 years (n=124 cycles), 32 to 36 years (n=184 cycles), and 37 to 41 years (n=108 cycles). Since the number of cases was relatively low, patients less than 27 years and more than 41 years were excluded from this study. The rates of matured oocytes, fertilization, cultured high-quality embryos, transferred high-quality embryos, implantation, clinical pregnancy, and delivery were compared by maternal age between the obstructive azoospermia (OA, n=301 cycles) and non-obstructive azoospermia (NOA, n=115 cycles) groups. Male patients were evaluated, and azoospermia was classified as described previously \[[@B2][@B19]\]. Institutional review board approval was obtained for this study.

2. Ovarian stimulation and oocyte retrieval
-------------------------------------------

Controlled ovarian hyperstimulation was performed in female patients using a gonadotropin-releasing hormone agonist/antagonist protocol with human menopausal gonadotropin or recombinant follicle-stimulating hormone. Oocyte retrieval was performed via a transvaginal approach with sonographic guidance 36 hours after the administration of 10,000 IU of human chorionic gonadotropin (hCG) (Pregnyl, Organon, Haarlem, The Netherlands). The retrieved oocytes were incubated in G-Fert medium (Vitrolife, Kungsbacka, Sweden) supplemented with 10% human serum albumin solution (Vitrolife). Oocytes were maintained at 37℃ in a 6% CO~2~ atmosphere. At 3 to 5 hours after oocyte retrieval, cumulus cell masses were removed by incubating the cells for 1 minute in gamete medium supplemented with 0.05% hyaluronidase (Sigma, St. Louis, MO, USA).

3. TESE and preparation
-----------------------

The TESE and sperm preparation procedures have been described in detail elsewhere \[[@B1][@B2][@B20]\]. Briefly, testicular tissue was excised and rinsed with Quinn\'s Sperm Washing medium (SAGE, CooperSurgical, Trumbull, CT, USA). The tissue was squeezed with fine forceps, and the presence of spermatozoa was confirmed (×200--×400 magnification). The retrieved testicular spermatozoa were transferred to Gamete medium (Vitrolife) and maintained in an incubator at 37℃ and 6% CO~2~ until the ICSI procedure (approximately 3--5 hours).

4. ICSI procedure, assessment of fertilization, and embryo development
----------------------------------------------------------------------

Suspensions of testicular sperm were loaded into 10-µL drops of gamete medium, and sperm motility was evaluated. Motile sperm were transferred to a droplet of 7% polyvinylpyrrolidone solution (SAGE) for immobilization, and individual oocytes were placed in droplets of buffered Gamete medium. After injection, the oocytes were washed and transferred to fertilization medium (G-FERT, Vitrolife). At 16 to 18 hours after ICSI, the oocytes were observed under an inverted microscope for any signs of damage due to the microinjection and for the presence of pronuclei. Normal fertilization was defined as the presence of two clearly visible pronuclei. Fertilized embryos were transferred to G-1.5 medium (Vitrolife). Embryo cleavage of the two-pronuclear oocytes was evaluated after 48 additional hours of *in vitro* culture (day 3). Embryos were assessed according to a previously described embryo grading system \[[@B1][@B2][@B21][@B22]\]. Embryos were graded according to the following criteria: grade I embryos, even blastomeres and no fragmentation; grade I-1 embryos, even blastomeres and \<25% fragmentation; grade II embryos, uneven blastomeres and \<25% fragmentation; grade II-1 embryos, uneven blastomeres and 25% to 50% fragmentation; and grade III embryos, even or uneven blastomeres and ≥50% fragmentation. Cryopreserved pronuclear stage embryos were excluded from the total of cleavage-stage embryos. High-quality embryos were considered to be embryos of grade I, I-1, or II.

5. ET and establishment of pregnancy
------------------------------------

The embryos were transferred into the uterine cavity 3 to 5 days after oocyte retrieval. Pregnancy was defined as a serum β-hCG level over 5 mIU/mL at 12 days after oocyte retrieval. Clinical pregnancy was defined as the presence of a gestational sac 5 to 7 gestational weeks after ET. The implantation rate was calculated as the number of gestational sacs observed divided by the number of transferred embryos. The pregnancy, clinical pregnancy, and delivery rates were calculated per complete ET cycle.

6. Statistical analysis
-----------------------

Statistical analysis was performed using SPSS ver. 12.0 (SPSS Inc., Chicago, IL, USA). Fertilization rates, numbers of cleavage-stage embryos, and numbers of high-quality embryos were compared among the three groups using one-way analysis of variance. Categorical data were analyzed using the Pearson chi-square test. Numerical data for the two groups of interest were compared by investigating their degree of correlation and performing the Student\'s *t*-test and chi-square test. Differences were considered statistically significant at *p*\<0.05.

Results
=======

A total of 6,099 stimulated oocytes were retrieved, and 76.5% of the matured oocytes were used to perform ICSI ([Table 1](#T1){ref-type="table"}). The male partner\'s age was significantly different among the age groups (*p*\<0.001). The fertilization and high-quality embryo rates were 71.5% and 61.2%, respectively. The clinical pregnancy rate was 37.1%, and the delivery rate was 31.3%. Among the maternal age groups, the fertilization and good embryo rates were not different. In the 27 to 31 years age group, the cultured high-quality embryo rate was lower than in the other groups, although this difference was not significant. The mean number of transferred embryos was 2.9±1.0; this number was not significantly different among the age groups. The clinical pregnancy and delivery rates were lower in the 37 to 41 years age group than in the 32 to 36 years age group; however, this difference was not significant.

Both the male partner\'s age (*p*\<0.001) and the female partner\'s age (*p*\<0.05) were significantly different between the OA and NOA groups ([Table 2](#T2){ref-type="table"}). Moreover, the fertilization rate was significantly higher in the OA group than in the NOA group (75.2% vs. 61.8%, *p*\<0.05). The total mean number of transferred embryos was 2.9±1.0, which was also not different between the two groups (2.9±1.0 vs. 2.9±1.0). Furthermore, the clinical pregnancy and delivery rates were not significantly different between the OA and NOA groups (37.5% vs. 35.8% and 31.3% vs. 31.6%, respectively).

The influences of OA and NOA according to maternal age group are shown in [Table 3](#T3){ref-type="table"}. The male partner\'s age was significantly different between the 27 to 31 years and 37 to 41 years age groups (*p*\<0.05). The rates of fertilization, cultured high-quality embryos, and transferred high-quality embryos were significantly different in the 27 to 31 years age group (*p*\<0.05, *p*\<0.001). In contrast, the other age groups showed similar results between the OA and NOA groups. However, in the 32 to 36 years age group, the implantation rates of the OA and NOA groups were significantly different (*p*\<0.05). Although the clinical pregnancy and delivery rates were different between the OA and NOA groups in all of the age groups, significant differences were not observed.

Discussion
==========

Prolonged life expectancy is associated with changing patterns of marriage and divorce. Specifically, remarriage and the wish to fath a child in a new partnership are both becoming increasingly common \[[@B23]\]. Moreover, delaying childbirth has also become a trend and is especially common in developed countries, reflecting increased life expectancy and the changing role of women in society. However, as the ages of both partners increase, so do the risks of reproductive problems \[[@B24]\].

One of the most important factors influencing pregnancy success is maternal age \[[@B25]\]. Female fertility is well known to decrease as age increases \[[@B16][@B24]\]. Many reports have demonstrated the effects of aging on the ovarian response to stimulation and the fertilization rate. Aging has also been shown to contribute to decreased pregnancy and birth rates in assisted reproduction programs \[[@B26]\]. Advanced maternal age is associated with decreased numbers of retrieved oocytes \[[@B27]\] and reduced fertilization and implantation rates \[[@B28][@B29]\]. In addition, advanced maternal age has been shown to be associated with a decreased pregnancy rate, an increased spontaneous miscarriage rate, congenital anomalies, and a decreased delivery rate \[[@B24][@B30]\].

While female fertility peaks between the ages of 22 to 26 years, the age-related decrease in fertility first becomes prominent at the age of 35 years. This age is a discrete time point after which women exhibit significantly increased risks of adverse reproductive outcomes \[[@B11][@B13][@B24][@B31][@B32][@B33]\]. Previous studies have compared outcomes of women 40 years of age or older versus those of women younger than 40 years \[[@B34][@B35]\]. Another study demonstrated reduced fertility in women over 37 years of age \[[@B36]\]. By the age of 40 years, the likelihood of success for ART declines sharply \[[@B26][@B37]\], and the chance of a successful pregnancy is low in women aged ≥41 years \[[@B11]\]. Therefore, we stratified patients by age into three groups (27--31 years, 32--36 years, and 37--41 years).

It has been postulated that the ovarian response to gonadotropin stimulation diminishes with increasing age. Decreased responsiveness of the ovary to gonadotropins, fewer collected eggs, and an increased cancellation rate are all associated with failure to achieve pregnancy \[[@B34][@B38]\]. Hughes et al. \[[@B39]\] suggested that early deterioration of granulosa cell function can be detected by a reduction in serum inhibin level; progressive follicular depletion and reduced granulosa cell function have also been suggested as factors contributing to the reduced fecundity observed with increasing age \[[@B26]\]. Female-related parameters, such as age and number of retrieved oocytes, may also have a significant contribution to the success of pregnancy \[[@B40]\]. From this perspective, Lee et al. \[[@B21]\] also reported that the female partner\'s age, number of matured oocytes, oocyte status, number of oocytes available for ICSI, and number of transferred embryos all affected *in vitro* fertilization outcomes. The observed decreases in ovarian reserve and endometrial receptivity are probable reasons for the reduced fertility associated with aging \[[@B11]\]. This decline becomes obvious at the age of 35 years. These effects can be explained partly by the age-related decrease in follicular reserve and the increased chromosomal anomaly rates in the oocytes \[[@B41]\], the latter of which is probably associated with the aging cytoplasm and increased aneuploidy rates during meiosis \[[@B42]\].

The deterioration in oocyte quality observed with increasing maternal age has been postulated as a contributing factor to reduced fertilization rates \[[@B26][@B43][@B44]\]. Moreover, poor oocyte quality has been shown to contribute to increased fetal loss in older women \[[@B35][@B44]\]. In our study, the matured oocyte and fertilization rates were not significantly different among the age groups. Additionally, maternal aging has been associated with increased spontaneous miscarriage rate, pregnancy complications, congenital anomalies, and higher perinatal mortality \[[@B24]\]. Delivery rates decrease by 50% for women aged 38 to 40 years and by another 50% by the age of 40 years \[[@B30]\]. In contrast, De Croo et al. \[[@B36]\] reported that maternal age less than 37 years did not influence fertilization or implantation results. Ishikawa et al. \[[@B3]\] reported that the pregnancy and delivery rates depended strictly on the age of the female partner, but not on her ovarian reserve or on the azoospermia prognosis. In addition, good fertilization rates were achieved without significant differences between the sperm sources. In our previous report \[[@B19]\], the overall fertilization rate per cycle was lower in the NOA group than in the OA group, but the embryo development and pregnancy rates per cycle did not differ between the OA and NOA groups. However, in the present study, the cultured high-quality embryo rate (*p*\<0.05) and transferred high-quality embryo rate (*p*\<0.001) were significantly different between the OA and NOA groups in women aged 27 to 31 years. This result suggests that even though the age of the couple was relatively young in this group, the diminished outcomes could have been affected by early and late paternal factors. These outcomes could also be attributed to poor embryo development due to deleterious factors specific to NOA.

Another important way in which the pregnancy rate can potentially be increased is by increasing the number of embryos transplanted into the uterus in older women \[[@B32][@B45][@B46]\]. The assisted reproduction outcomes of women aged 40 years and older could potentially be improved by transferring more than three oocytes to compensate for the poorer implantation rates \[[@B26]\]. However, we observed that the mean number of transferred embryos was 2.9±1.0, and that this number was similar between the different age groups. Increasing the transfer of high-quality embryos with faster growth rates into the uterus is another strategy for potentially increasing pregnancy rates in older women \[[@B5]\]. Altay et al. \[[@B5]\] found no significant difference between the fertilization and cleavage rates of younger versus older women, but did detect a significant difference in the pregnancy rates of these two groups. We found that the clinical pregnancy and delivery rates declined from the 32--36 years to the 37--41 years group, but these differences were not significant. Since aging is a highly complex and incompletely understood process, clinicians often have difficulty engaging patients in a meaningful discussion of advancing maternal age \[[@B47]\]. Since the live birth rate is extremely poor in women 40 years of age and older, the possibilities of poor outcomes versus the best possible outcome should be explained to the couple before offering assisted reproduction to women of this age. Additionally, the possibility of using donor eggs should be discussed \[[@B26]\].

In conclusion, our data suggest that maternal age does not affect pregnancy or delivery outcomes for couples using testicular sperm from patients with azoospermia. However, women older than 37 years using testicular sperm from patients with azoospermia should be advised of the probability of poor pregnancy outcomes.
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###### Effect of maternal age on outcomes in patients with azoospermic partners
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Values are presented as mean±standard deviation unless otherwise indicated.

FSH, follicle-stimulating hormone; ET, embryo transfer.

^a)^*p*\<0.001.

###### Comparison of the influence of maternal age in the OA and NOA groups
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Values are presented as mean±standard deviation unless otherwise indicated.

OA, obstructive azoospermia; NOA, non-obstructive azoospermia; FSH, follicle-stimulating hormone; ET, embryo transfer.

^a)^*p*\<0.05; ^b)^*p*\<0.001.

###### Comparison of outcomes in the OA and NOA groups across different maternal age groups
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Values are presented as mean±standard deviation unless otherwise indicated.

OA, obstructive azoospermia; NOA, non-obstructive azoospermia; FSH, follicle-stimulating hormone; ET, embryo transfer.

^a)^*p*\<0.05; ^b)^*p*\<0.001.
